Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Comment by invest1on Nov 19, 2016 6:51pm

144 Views

Post# 25485614

RE:RE:AGM..DEC 22/16.. #7-CONSOLIUDATION AUTHORIZATION

I'll be selling after Clone Gold results (good or bad) are released in 2 to 3 weeks. If results are bad, will go back to a penny, if good, will go to 5 cents or higher. Either way I want to avoid this consolidation of 20 to1.

Also if gold cloneproperty results are good and stock goes over 5 cents, many warrants will be exercised at 5 cents , and then this will provide the financing for their next drilling season next spring at the Clone Property .

Here's hoping!!!!!!!!!!!

Bullboard Posts

Visionstate set to leverage success in the U.S. market